Literature DB >> 11581386

A commonly recognized simian immunodeficiency virus Nef epitope presented to cytotoxic T lymphocytes of Indian-origin rhesus monkeys by the prevalent major histocompatibility complex class I allele Mamu-A*02.

S Robinson1, W A Charini, M H Newberg, M J Kuroda, C I Lord, N L Letvin.   

Abstract

The ability to monitor vaccine-elicited CD8(+) cytotoxic T-lymphocyte (CTL) responses in simian immunodeficiency virus (SIV)- and simian-human immunodeficiency virus (SHIV)-infected rhesus monkeys has been limited by our knowledge of viral epitopes predictably presented to those lymphocytes by common rhesus monkey MHC class I alleles. We now define an SIV and SHIV Nef CTL epitope (YTSGPGIRY) that is presented to CD8(+) T lymphocytes by the common rhesus monkey MHC class I molecule Mamu-A*02. All seven infected Mamu-A*02(+) monkeys evaluated demonstrated this response, and peptide-stimulated interferon gamma Elispot assays indicated that the response represents a large proportion of the entire CD8(+) T-lymphocyte SIV- or SHIV-specific immune response of these animals. Knowledge of this epitope and MHC class I allele substantially increases the number of available rhesus monkeys that can be used for testing prototype HIV vaccines in this important animal model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11581386      PMCID: PMC114592          DOI: 10.1128/JVI.75.21.10179-10186.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule.

Authors:  M Furchner; A L Erickson; T Allen; D I Watkins; A Sette; P R Johnson; C M Walker
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

Authors:  D H Barouch; S Santra; J E Schmitz; M J Kuroda; T M Fu; W Wagner; M Bilska; A Craiu; X X Zheng; G R Krivulka; K Beaudry; M A Lifton; C E Nickerson; W L Trigona; K Punt; D C Freed; L Guan; S Dubey; D Casimiro; A Simon; M E Davies; M Chastain; T B Strom; R S Gelman; D C Montefiori; M G Lewis; E A Emini; J W Shiver; N L Letvin
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

3.  Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity.

Authors:  H Yamamoto; M D Miller; H Tsubota; D I Watkins; G P Mazzara; V Stallard; D L Panicali; A Aldovini; R A Young; N L Letvin
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

4.  NK susceptibility varies inversely with target cell class I HLA antigen expression.

Authors:  W J Storkus; D N Howell; R D Salter; J R Dawson; P Cresswell
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

5.  Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.

Authors:  M A Egan; W A Charini; M J Kuroda; J E Schmitz; P Racz; K Tenner-Racz; K Manson; M Wyand; M A Lifton; C E Nickerson; T Fu; J W Shiver; N L Letvin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.

Authors:  M D Miller; H Yamamoto; A L Hughes; D I Watkins; N L Letvin
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

7.  Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes.

Authors:  L Shen; Z W Chen; M D Miller; V Stallard; G P Mazzara; D L Panicali; N L Letvin
Journal:  Science       Date:  1991-04-19       Impact factor: 47.728

8.  Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.

Authors:  H Rabin; R H Neubauer; R F Hopkins; E K Dzhikidze; Z V Shevtsova; B A Lapin
Journal:  Intervirology       Date:  1977       Impact factor: 1.763

9.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene.

Authors:  M D Daniel; F Kirchhoff; S C Czajak; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

10.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

View more
  10 in total

1.  Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?

Authors:  Thorsten U Vogel; Thomas C Friedrich; David H O'Connor; William Rehrauer; Elizabeth J Dodds; Heather Hickman; William Hildebrand; John Sidney; Alessandro Sette; Austin Hughes; Helen Horton; Kathy Vielhuber; Richard Rudersdorf; Ivna P De Souza; Matthew R Reynolds; Todd M Allen; Nancy Wilson; David I Watkins
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.

Authors:  Fred W Peyerl; Heidi S Bazick; Michael H Newberg; Dan H Barouch; Joseph Sodroski; Norman L Letvin
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Diverse peptide presentation of rhesus macaque major histocompatibility complex class I Mamu-A 02 revealed by two peptide complex structures and insights into immune escape of simian immunodeficiency virus.

Authors:  Jun Liu; Lianpan Dai; Jianxun Qi; Feng Gao; Youjun Feng; Wenjun Liu; Jinghua Yan; George F Gao
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

4.  Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge.

Authors:  Matthew R Reynolds; Andrea M Weiler; Shari M Piaskowski; Holly L Kolar; Ann J Hessell; Madelyn Weiker; Kim L Weisgrau; Enrique J León; W Eric Rogers; Robert Makowsky; Adrian B McDermott; Rosanne Boyle; Nancy A Wilson; David B Allison; Dennis R Burton; Wayne C Koff; David I Watkins
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

6.  Epitope-specific CD8+ T lymphocytes cross-recognize mutant simian immunodeficiency virus (SIV) sequences but fail to contain very early evolution and eventual fixation of epitope escape mutations during SIV infection.

Authors:  Evan M Cale; Peter Hraber; Elena E Giorgi; Will Fischer; Tanmoy Bhattacharya; Thomas Leitner; Wendy W Yeh; Cheryl Gleasner; Lance D Green; Cliff S Han; Bette Korber; Norman L Letvin
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

7.  Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection.

Authors:  Jacob T Minang; Matthew T Trivett; Diane L Bolton; Charles M Trubey; Jacob D Estes; Yuan Li; Jeremy Smedley; Rhonda Pung; Margherita Rosati; Rashmi Jalah; George N Pavlakis; Barbara K Felber; Michael Piatak; Mario Roederer; Jeffrey D Lifson; David E Ott; Claes Ohlen
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

8.  Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes.

Authors:  Masahiko Kaizu; Gretta J Borchardt; Chrystal E Glidden; Debra L Fisk; John T Loffredo; David I Watkins; William M Rehrauer
Journal:  Immunogenetics       Date:  2007-07-20       Impact factor: 2.846

9.  Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.

Authors:  John T Loffredo; Alex T Bean; Dominic R Beal; Enrique J León; Gemma E May; Shari M Piaskowski; Jessica R Furlott; Jason Reed; Solomon K Musani; Eva G Rakasz; Thomas C Friedrich; Nancy A Wilson; David B Allison; David I Watkins
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

10.  CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.

Authors:  John T Loffredo; Thomas C Friedrich; Enrique J León; Jason J Stephany; Denise S Rodrigues; Sean P Spencer; Alex T Bean; Dominic R Beal; Benjamin J Burwitz; Richard A Rudersdorf; Lyle T Wallace; Shari M Piaskowski; Gemma E May; John Sidney; Emma Gostick; Nancy A Wilson; David A Price; Esper G Kallas; Helen Piontkivska; Austin L Hughes; Alessandro Sette; David I Watkins
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.